AngioDynamics, Inc. Reports Net Loss of $21.5 Million for the Fourth Quarter
AngioDynamics, Inc. Announces Revenue of $91.1 Million for the Fourth Quarter
AngioDynamics, Inc.(ANGO), a leading provider of med ical devices, has released its financial results for the fourth quarter ended May 31, 2023. The company reported a net loss of $21.5 million, compared to a net loss of $6.3 million in the same period last year. Despite the loss, AngioDynamics achieved revenue of $91.1 million, representing a 4.7% increase compared to the fourth quarter of the previous year.
Net Loss and Operating Performance
AngioDynamics reported a net loss of $21.5 million for the fourth quarter, reflecting a significant increase from the net loss of $6.3 million in the same period last year. The company's operating loss amounted to $20.8 million, compared to an operating loss of $6.4 million in the previous year.
Revenue Growth